# US 2024/0240195 A1 · Compositions and methods for increasing extractibility of solids from coffee beans

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0240195 A1
- Document ID: US20240240195A1
- Status: Published application
- Kind: A1
- Application number: 18/584,965
- Filed: 2024-02-22
- Published: 2024-07-18
- Earliest claimed: 2017-05-31
- Assignees: Tropic Biosciences UK Limited
- Applicants: Tropic Biosciences UK Limited
- Inventors: Eyal MAORI; Yaron GALANTY; Cristina PIGNOCCHI; Angela CHAPARRO GARCIA; Ofir MEIR
- Web page: https://patentgrep.com/patent/US20240240195A1

## CPC

- C12N 15/8243: {involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine}
- A23F 5/02: Treating green coffee; Preparations produced thereby (roasting A23F5/04; removing unwanted substances A23F5/16; reducing or removing alkaloid content A23F5/20; extraction A23F5/24)
- A23F 5/26: Extraction of water soluble constituents {(A23F5/246 takes precedence)}
- A23F 5/486: {by distillation from beans that are ground or not ground, e.g. stripping; Recovering volatile gases, e.g. roaster or grinder gases}
- C12N 9/2465: {acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22)}
- C12N 15/8213: {Targeted insertion of genes into the plant genome by homologous recombination}
- C12Y 302/01022: Alpha-galactosidase (3.2.1.22)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A23F: COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- C12Y: ENZYMES

## Abstract

A coffee plant comprising a genome comprising a loss of function mutation in a nucleic acid sequence encoding alpha-D-galactosidase. Also provided is a method of increasing extractability of solids from coffee beans. In addition there is provided a method of producing soluble coffec.

## Claims

### Claim 1

A coffee plant comprising a genome comprising a loss of function mutation in a nucleic acid sequence encoding alpha-D-galactosidase.

### Claim 2

A method of increasing extractability of solids from coffee beans, the method comprising:
(a) subjecting a coffee plant cell to a DNA editing agent directed at a nucleic acid sequence encoding alpha-D-galactosidase to result in a loss of function mutation in said nucleic acid sequence encoding said alpha-D-galactosidase; and
(b) regenerating a plant from said plant cell.

### Claim 3 (depends on 2)

The method of claim 2 further comprising harvesting beans from said plant.

### Claim 4 (depends on 1, 2, 3)

The plant or method of any one of claims 1-3, wherein said mutation is in a homozygous form.

### Claim 5 (depends on 1, 2, 3)

The plant or method of any one of claims 1-3, wherein said mutation is in a heterozygous form.

### Claim 6 (depends on 1, 4)

The plant of claim 1 or 4 or ancestor thereof having been treated with a DNA editing agent directed to said genomic sequence encoding alpha-D-galactosidase.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The plant or method of any one of claims 1-6, wherein said mutation is selected from the group consisting of a deletion, an insertion an insertion/deletion (Indel) and a substitution.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The plant or method of any one of claims 1-7, wherein said coffee plant is from a species Coffea arabica.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7)

The plant or method of any one of claims 1-7, wherein said coffee plant is from a species Coffea canephora.

### Claim 10 (depends on 2)

The method of claim 2, wherein said subjecting is to a nucleic acid construct encoding said DNA editing agent.

### Claim 11 (depends on 2)

The method of claim 2, wherein said subjecting is by a DNA-free delivery method.

### Claim 12

A nucleic acid construct comprising a nucleic acid sequence encoding a DNA editing agent directed at coffee alpha-D-galactosidase being operably linked to a plant promoter.

### Claim 13 (depends on 2, 3, 4, 5, 6, 7, 8, 9)

The plant, method or nucleic acid construct of any one of claims 2-9, wherein said DNA editing agent is of a DNA editing system selected from the group consisting of selected from the group consisting of meganucleases, Zinc finger nucleases (ZFNs), transcription-activator like effector nucleases (TALENs) and CRISPR-Cas.

### Claim 14 (depends on 2, 3, 4, 5, 6, 7, 8, 9)

The plant, method or nucleic acid construct of any one of claims 2-9, wherein said DNA editing agent is of a DNA editing system comprising CRISPR-Cas.

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The plant, method or nucleic acid construct of any one of claims 1-14, wherein said nucleic acid sequence encoding alpha-D-galactosidase is as set forth in SEQ ID NO: 4.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The plant, method or nucleic acid construct of any one of claims 1-14, wherein said nucleic acid sequence encoding alpha-D-galactosidase is selected from the group consisting of SEQ ID NOs: 2-4.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The plant, method or nucleic acid construct of any one of claims 1-14, wherein said nucleic acid sequence encoding alpha-D-galactosidase is as set forth in SEQ ID NO: 2.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The plant, method or nucleic acid construct of any one of claims 1-14, wherein said nucleic acid sequence encoding alpha-D-galactosidase is as set forth in SEQ ID NO: 3.

### Claim 19 (depends on 2, 4, 5, 6, 7, 8, 9, 13, 14)

The plant, method or nucleic acid construct of any one of claims 2, 4-9, 13-14, wherein said DNA editing agent is directed at nucleic acid coordinates within exon 1, 2, 3, 4 and/or 5 of a nucleic acid sequence encoding said alpha-D-galactosidase.

### Claim 20 (depends on 2, 4, 5, 6, 7, 8, 9, 13, 14, 19)

The plant, method or nucleic acid construct of any one of claims 2, 4-9, 13-14 and 19, wherein said DNA editing agent comprises a nucleic acid sequence at least 99% identical to a nucleic acid sequence selected from the group consisting of SEQ ID NO: 38-41.

### Claim 21 (depends on 2, 4, 5, 6, 7, 8, 9, 13, 14, 19)

The plant, method or nucleic acid construct of any one of claims 2, 4-9, 13-14 and 19, wherein said DNA editing agent comprises a nucleic acid sequence at least 99% identical to a nucleic acid sequence selected from the group consisting of SEQ ID NO: 9-11 and 37.

### Claim 22 (depends on 2, 4, 5, 6, 7, 8, 9, 13, 14, 19)

The plant, method or nucleic acid construct of any one of claims 2, 4-9, 13-14 and 19, wherein said DNA editing agent comprises a nucleic acid sequence selected from the group consisting of SEQ ID NO: 38-41.

### Claim 23 (depends on 2, 4, 5, 6, 7, 8, 9, 13, 14, 19)

The plant, method or nucleic acid construct of any one of claims 2, 4-9, 13-14 and 19, wherein said DNA editing agent comprises a plurality of nucleic acid sequences selected from the group consisting of SEQ ID NOs: 9-11 and 37.

### Claim 24 (depends on 2, 4, 5, 6, 7, 8, 9, 13, 14, 19)

The plant, method or nucleic acid construct of any one of claims 2, 4-9, 13-14 and 19, wherein said DNA editing agent is directed to a plurality of alpha-D-galactosidase genes.

### Claim 25 (depends on 24)

The plant, method or nucleic acid construct of claim 24, wherein said plurality of alpha-D-galactosidase genes are selected from the group consisting of SEQ ID NOs: 2-4.

### Claim 26 (depends on 24)

The plant, method or nucleic acid construct of claim 24, wherein said plurality of alpha-D-galactosidase genes are selected from the group consisting of SEQ ID NOs: 3-4.

### Claim 27 (depends on 24)

The plant, method or nucleic acid construct of claim 24, wherein said plurality of alpha-D-galactosidase genes are selected from the group consisting of SEQ ID NOs: 1-2.

### Claim 28 (depends on 24)

The plant, method or nucleic acid construct of claim 24, wherein said plurality of alpha-D-galactosidase genes are selected from the group consisting of SEQ ID NOs: 1 and 3.

### Claim 29 (depends on 1, 4, 5, 6, 7, 8, 9, 13, 14, 15, 16, 17, 18, 19, 20, 21)

A plant part of the plant of any one of claims 1, 4-9, 13-21.

### Claim 30 (depends on 29)

The plant part of claim 29 being a bean.

### Claim 31 (depends on 30)

The bean of claim 30 being dry.

### Claim 32 (depends on 1, 4, 5, 6, 7, 8, 9, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)

A method of producing coffee beans, the method comprising:
(a) growing the plant of any one of claims 1, 4-9 and 13-28; and
(b) harvesting beans from the plant.

### Claim 33 (depends on 30)

A method of producing soluble coffee, the method comprising subjecting beans of claim 30 to extraction, dehydration and optionally roasting.

### Claim 34 (depends on 30, 31)

Soluble coffee of the beans of claim 30-31.

### Claim 35 (depends on 34)

The soluble coffee of claim 34, being in a powder form.

### Claim 36 (depends on 34)

The soluble coffee of claim 34, being in a granulated form.

### Claim 37 (depends on 34, 35, 36)

The soluble coffee of any one of claims 34-36, being decaffeinated.

### Claim 38 (depends on 30, 31, 34, 35, 36, 37)

The soluble coffee of any one of claims 34-37, comprising DNA of the beans of any one of claims 30-31.

### Claim 39 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)

The plant or method of any one of claims 1-32, wherein the plant is non-transgenic.
